Illumina names new commercial, legal chiefs as sequencing business shows signs of stability
Illumina has filled two key C-suite posts, naming Mike Sullivan as chief commercial officer and Julie Coletti as chief legal officer as the DNA sequencing giant works to keep its turnaround on track…
Read the full articleYou might also wanna read

Illumina Launches WGS Study with European Newborn Sequencing Projects
Illumina will reanalyze genomes from children with unresolved cases and, for select patients, re-sequence their genomes using the new TruPat
Strategic Leadership Appointments Announced at Quandela, Zapata Quantum, Imperagen, and EigenQ
Quandela has announced a major restructuring of its executive leadership and governance to drive the international scale-up of its photonic

Illumina Doubles Down on Newborn Sequencing: Ion Genomics Newsletter, June 23, 2026
10x teams up with Cleveland Clinic, Norway embraces nanopore-based brain cancer dx, Guardant-TwinStrand legal update, a World Cup-related co
Illumina NovaSeq X outperforms MGI DNBSEQ-T7 in head-to-head whole-genome sequencing comparison
A head-to-head comparison evaluated WGS using the MGI DNBSEQ-T7 sequencing platform with MegaBOLT v2.4.0 software against the NovaSeq X Seri
Bill Holdings restructures leadership, appoints new chief product and technology officers
Business payments company Bill Holdings named new leaders for product, technology and revenue roles amid a broader restructuring.
Lucid Motors CFO departs as new CEO Napoli reshuffles leadership amid slow Gravity SUV sales
The company announced a new slate of executive hires meant to help turn things around, as Gravity SUV sales are not taking off as expected.

Comments
Sign in to join the conversation.
No comments yet. Be the first.